Published in Virology on April 08, 2015
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature (2017) 1.81
New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication. PLoS Pathog (2015) 0.80
DNA-launched live-attenuated vaccines for biodefense applications. Expert Rev Vaccines (2016) 0.78
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain. PLoS One (2017) 0.76
Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulence. Antiviral Res (2016) 0.75
Attenuated Infectious Hematopoietic Necrosis Virus with Rearranged Gene Order as Potential Vaccine. J Virol (2016) 0.75
Experimental evolution of an RNA virus in cells with innate immunity defects. Virus Evol (2015) 0.75
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Systems Biology Approach for Cancer Vaccine Development and Evaluation. Vaccines (Basel) (2015) 0.75
Current trends in Zika vaccine development. J Virus Erad (2017) 0.75
The mechanism by which P250L mutation impairs flavivirus-NS1 dimerization: an investigation based on molecular dynamics simulations. Eur Biophys J (2016) 0.75
Viral Population Changes during Murine Norovirus Propagation in RAW 264.7 Cells. Front Microbiol (2017) 0.75